Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
15,580,222
-
Share change
-
+88,541
-
Total reported value
-
$96,502,272
-
Put/Call ratio
-
119%
-
Price per share
-
$6.18
-
Number of holders
-
70
-
Value change
-
-$1,095,075
-
Number of buys
-
33
-
Number of sells
-
24
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2017
As of 30 Sep 2017,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,580,222 shares.
The largest 10 holders included
Versant Venture Management, LLC, JENNISON ASSOCIATES LLC, SV Health Investors, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, COLUMBUS CIRCLE INVESTORS, VANGUARD GROUP INC, STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
70
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.